10x Genomics Inc (NAS:TXG)
$ 24.09 -0.74 (-2.98%) Market Cap: 2.88 Bil Enterprise Value: 2.69 Bil PE Ratio: 0 PB Ratio: 4.01 GF Score: 75/100

10X Genomics Inc Annual Shareholders Meeting Transcript

Jun 11, 2021 / 08:30PM GMT
Release Date Price: $193.51 (+1.23%)
Serge Saxonov
10x Genomics, Inc. - Co-Founder, CEO & Director

Good afternoon. I want to welcome all of you to the 2021 Annual Meeting of Stockholders of 10x Genomics, Inc. and call this meeting to order.

I'm Serge Saxonov of Co-Founder and Chief Executive Officer and a member of the Board of Directors of 10x Genomics, and I will act as Chairperson of the meeting.

Justin McAnear, our Chief Financial Officer, joins me in welcoming you today. I would also like to welcome the members of our Board of Directors and our executive team who are present at today's meeting. James Bryant, 10x's Director of Legal will act the secretary of the meeting.

In addition, I'm pleased to welcome Dan Coleman, a representative of Ernst & Young, our external auditing firm, who is here to answer any appropriate questions.

Finally, I'd like to welcome Kris Veaco, a representative of Broadridge Financial Solutions, who has taken her oath and been important to act as our inspector of election.

Justin J. McAnear
10x Genomics, Inc. - CFO

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot